Negotiated Procedure Pursuant To Articles. 25 And 50 Co. 1 Letter B Of The Legislative Decree. 36/2023 And Subsequent Amendments. With The Right To Increase Performance Up To A Fifth Of The Contract Amount, Pursuant To Art. 120, Paragraph 9, Of Legislative Decree No. 36/2023 And Subsequent Amendments, For The Supply Of The Active Ingredients Sodium Thiosulfate, Eosin, Cabergolin, Lorazepam, Doxycycline, Lacosamide, Rosuvastatin, Dorzolamide Hydrochloride-Thymolol Maleate, Pregabalin, Imatinib, Losartan Potassium, Simvastatin, Atenolol